Technology | Contrast Media Injectors | February 16, 2016

Guerbet Receives FDA 510k Clearance for OptiOne Single-Head Contrast Delivery System

Entry-level injector offers advanced multipurpose functionality for CT imaging procedures

Guerbet, OptiOne single-head contrast delivery system, FDA 510k clearance

February 16, 2016 — Guerbet announced that it has received 510K clearance from the U.S. Food and Drug Administration (FDA) for its OptiOne Single-Head Contrast Delivery System, featuring advanced multipurpose functionality for computed tomography (CT) imaging procedures.

The OptiOne is an entry-level single-head injector launched in 2015 on the European market, available in ceiling-suspended and pedestal form. It is designed for the injection of radiopaque contrast agents in the vascular system of patients to obtain diagnostic images in CT scan examinations.

Guerbet will present the injector at the upcoming European Congress of Radiology (ECR), March 2-6 in Vienna.

The system combines ease of use, multipurpose functionality and optimized contrast media usage. It is designed to be adaptable to the workflow of the imaging department, providing a fully programmable powerhead with intuitive bedside operation and flexibility of use with the ability to accommodate prefilled or empty syringes.

The OptiOne is intended for use by doctors, radiology technologists and other licensed medical practitioners in a healthcare facility or hospital with CT equipment. Each injection is accomplished with a motor-driven syringe mechanism with microprocessor control of the flow rate, volume, pressure and timing. 

OptiOne is manufactured by Cincinnati, Ohio-based Liebel-Flarsheim, a company acquired by Guerbet as part of its purchase of Mallinckrodt's Contrast Media and Delivery Systems business announced on Nov. 27, 2015.

For more information: www.guerbet.com

Related Content

An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Canon Medical Systems.

An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Canon Medical Systems.

News | Cardiac Imaging | September 25, 2020
September 25, 2020 — A study out of University Hospitals (UH) found that removing the cost barrier for coronary arter
New research from King's College London has found that COVID-19 may be diagnosed on the same emergency scans intended to diagnose stroke.

Canon Medical Systems

News | Cardiac Imaging | September 22, 2020
September 22, 2020 — New research from King's College London has
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
Figure 1. Doppler flows in subpleural consolidation shows smoothly dilated branching arteries

Figure 1. Doppler flows in subpleural consolidation shows smoothly dilated branching arteries 

Feature | Radiology Imaging | September 17, 2020 | By Robert Bard, M.D. PC, DABR, FASLM
COVID-19 is routinely studied using...
Through computed tomography (CT) imaging, WVU geologist James Lamsdell led a team that found evidence of air breathing in a 340 million-year-old sea scorpion, or eurypterid. This is one of the scans of the specimen

Through computed tomography (CT) imaging, WVU geologist James Lamsdell led a team that found evidence of air breathing in a 340 million-year-old sea scorpion, or eurypterid. This is one of the scans of the specimen. Image courtesy of James Lamsdell

News | Computed Tomography (CT) | September 11, 2020
September 11, 2020 — Scientists have long debated the respiratory workings of sea scorpions, but a new discovery by a
The solution leverages image transfer speed, tag morphing, and multi-vendor PACS capabilities to enable comprehensive image visualization and analysis at the point of care
News | Breast Imaging | September 03, 2020
September 3, 2020 — Based on its recent analysis of the global breast imaging workstation industry, Frost & Sulli
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...